The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia

Overview of attention for article published in Journal of Neuroinflammation, February 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 27,223 followers.

RT @Immuneadvisors: Fda approved HDAC inhibitor shows promise in #cerebralpalsy https://t.co/oi84bEBP2S $celz https://t.co/XlRbLZoT2E

Reply Repost Favourite

RT @Immuneadvisors: Fda approved HDAC inhibitor shows promise in #cerebralpalsy https://t.co/oi84bEBP2S $celz https://t.co/XlRbLZoT2E

Reply Repost Favourite

RT @Immuneadvisors: Fda approved HDAC inhibitor shows promise in #cerebralpalsy https://t.co/oi84bEBP2S $celz https://t.co/XlRbLZoT2E

Reply Repost Favourite

RESEARCH: FDA-approved HDAC inhibitor shows promise in #cerebralpalsy Read more: https://t.co/IFXvJt0IVE

Reply Repost Favourite

Fda approved HDAC inhibitor shows promise in #cerebralpalsy https://t.co/oi84bEBP2S $celz https://t.co/XlRbLZoT2E

Reply Repost Favourite